Why the Late NBPP Final Rule Has ACA Issuers Rechecking Rate Filings 

For some ACA issuers, the rate filing they submitted this spring may no longer line up cleanly with the rule it was meant to reflect. 

The Plan Year 2027 NBPP landed late in the filing cycle, after issuers had already been developing rates and plan designs for months. By the time the final rule arrived in May, plans and rates were already due in some states. 

That left some issuers filing against assumptions that were not yet final. Now the work is to compare those filings against the final rule and determine whether anything needs to be corrected, explained or documented before the review process moves further along. 

How the Late PY2027 NBPP Created a Rate Filing Gap 

Filing against a proposed rule is not new. Issuers build actuarial assumptions around proposed federal guidance every year, and in most years those assumptions hold up reasonably well by the time the rule is finalized. 

What made the PY2027 cycle different was the timing. CMS proposed the 2027 NBPP in February, while issuers were already developing rates, benefits and plan designs for the next year. The final rule didn’t arrive until May, after plans and rates were already due in some states. 

That left some teams making filing decisions before they knew exactly where the rule would land. Rate filings depend on actuarial assumptions, product decisions, internal approvals and state-specific documentation moving together. When the rule is still unsettled late in that process, teams may have to price, explain and document based on incomplete information. 

For issuers in that position, the filed rate is not necessarily wrong, but it may be incomplete. It was built on the best information available at the time, with assumptions that now need to be checked against what became final. 

Rate Assumptions ACA Issuers Should Recheck After the Final NBPP 

Two final-rule areas are especially important for issuers to review against filed assumptions: catastrophic plan eligibility and cost-sharing reduction payment methodology. Both can affect how rates were developed, how assumptions were documented and whether additional explanation is needed during review. 

Catastrophic Plan Eligibility and Rate Assumptions 

Catastrophic plans have historically been available to a limited population, including people under age 30 and people who qualify for certain hardship or affordability exemptions. The final 2027 NBPP expands access to catastrophic coverage, which can change the population those plans are expected to cover. For issuers that priced catastrophic plans before the final rule was available, enrollment mix, morbidity and expected claims assumptions may need to be checked against the final eligibility rules. 

Cost-Sharing Reduction Payment Methodology 

CSR assumptions affect how issuers account for reduced cost sharing for eligible enrollees. The final rule established the methodology issuers need to use. If a filing was built using a different approach, the issue may go beyond a technical worksheet update. It may need to be addressed in the actuarial memo, supporting documentation or refiling discussion with the state. 

4 Steps for ACA Issuers Reviewing Filed Rates After the Final NBPP 

It has been reported that state and federal regulators may allow insurers to refile rates through August 12, 2026, to account for policy changes. For issuers that filed before the final NBPP was available, that window creates a short but important opportunity to reconcile the filing against the final rule. 

Step 1: Compare filed assumptions against the final rule. 

Teams should confirm which NBPP assumptions were built into the original filing, where the final rule changed those assumptions and whether those changes create a rate-level impact. Catastrophic plan pricing and CSR payment methodology are two areas already showing documented filing impact, but they should not be the only areas reviewed. 

Step 2: Confirm the state-specific refiling path. 

Some states may have a clear mechanism for updated rates or supporting documentation. Others may require regulator discussion before anything is resubmitted. If a state does not allow a refile, the issuer still needs to document the issue, the rationale and the expected review implications.

Step 3: Connect the analysis back to the filing record. 

If the actuarial team identifies an assumption gap, that information can’t stay in an internal memo or meeting discussion. It needs to be reflected in the filing materials, correspondence, objection responses or internal documentation so the record is clear if a regulator or CMS reviewer asks why the filing does or does not match the final rule. 

Step 4: Keep pending litigation on the monitoring list. 

The 2027 NBPP is final, but active litigation means the implementation path may continue to move. A similar challenge to the prior year’s rule resulted in a stay of multiple provisions, so filing teams should know who owns that monitoring, who decides whether a new development affects the filing and how quickly the team can respond if something changes.

Final Rule Review Doesn’t End at Submission 

Submitting a rate filing doesn’t end the work when the rule changes after the filing was built. For issuers that filed before the final PY2027 NBPP was available, the next step is comparing the final rule against the assumptions already reflected in the filing: the actuarial memo, rate development, plan design decisions, supporting documentation and any state-specific filing record. 

If something no longer lines up, the question becomes operational. Can the filing be updated? Does the state expect a refile, an explanation or documentation in the existing record? Who owns the response if a regulator or CMS reviewer asks why the filing was built the way it was? 

Filed does not always mean finished. It means the filing record needs to be checked against what is now final, with enough documentation to support the decisions the issuer made under a compressed timeline. 

ClearFile helps health plans track regulatory changes from proposed rule to final filing impact, including NBPP review, rate filing support, DOI communication and QHP certification workflows. If your team is reviewing how the final 2027 NBPP affects filed rates or supporting documentation, let’s talk.

Share this post

Sign up for Newsletter

Get the latest ClearFile news, events and insights, delivered straight to your inbox.
By clicking Sign Up you’re confirming that you agree with our Terms and Conditions.
Featured

Related Articles

We’re sharing the secrets behind regulatory success for health plans.

Ready to simplify compliance and move forward with confidence?

Whether you’re expanding, renewing, or filing under pressure—ClearFile takes the guesswork out of the process and helps your team stay ahead.

ClearFile Services

Expert-led regulatory consulting, filings, and licensure support for health plans, PBMs, TPAs, and insurers—built to reduce risk, avoid delays, and unlock growth.

ClearFile SaaS

Our intelligent platform automates filings, tracks deadlines, and connects teams with real-time guidance—bringing clarity, speed and confidence to every step of compliance.

We're always innovating.

Our team is continuously inventing and launching new solutions. Subscribe to our newsletter for the latest news & updates from Penstock.